What it is

Khavinson short peptide studied in neuroprotection, memory, and focus models.

Also known as

Glu-Asp-Arg · Pineal bioregulator peptide · Khavinson pinealon

Overview

Pinealon is a Khavinson short peptide associated with pineal and cognitive research catalogs. Preclinical framing covers neuroprotection, memory, and focus-related endpoints in aging and stress models.

Like other Khavinson bioregulators, it is studied as a tissue-oriented signaling peptide rather than a broad stimulant. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• Neuroprotection endpoints in cognitive aging models

• • Memory and learning-task markers where studied

• • Focus and attention-adjacent behavioral readouts

• • Oxidative-stress measures in neural tissue models

• • Short-peptide pineal bioregulator pharmacology

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

Week 1–2: Early signaling and behavioral endpoints in acute neuro models; exposure establishing.

Week 3–4: Clearer cognitive, stress, or neuroprotective markers in short research windows.

Month 2–3: More stable memory, focus, or neuroplasticity-related endpoints in extended designs.

Month 3–6: Sustained neuro and aging-adjacent observations where longer protocols are used.

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.